Literature DB >> 35230916

LncRNA4474 inhibits renal fibrosis by regulating hepatocyte nuclear factor-1β through miR-615 modulation.

Yun Zhu1, Zhenyu Wang2, Zuohui Liang1, Shuangyan Xu1, Yirong Teng1, Xiaolan Li3, Yong Zeng1.   

Abstract

Long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) are involved in the development and progression of renal fibrosis. lncRNAs can regulate target messenger RNAs (mRNAs) by competitively binding to miRNAs. However, research on lncRNA-miRNA-mRNA interactions remains inadequate. Therefore, the aim of the present study was to investigate the possible function of lncRNA-miRNA-mRNA interactions in chronic renal fibrosis. The relationships among the expression levels of lncRNA4474, miR-615, and hepatocyte nuclear factor-1β (HNF-1β) mRNAs were determined through RNA sequencing. The biological roles of lncRNA4474, miR-615, and HNF-1β in renal fibrosis were investigated with gain-of-function and loss-of-function experiments. Results showed that miR-615 expression increased in unilateral ureteral obstruction rats, accompanied by decreased lncRNA4474 and HNF-1β mRNA expression. The overexpression of HNF-1β attenuated the development of chronic renal fibrosis, whereas HNF-1β knockdown promoted the development. Increase in HNF-1β expression downregulated and upregulated the expression levels of miR-615 and lncRNA4474, respectively, thereby attenuating renal fibrosis progression. Furthermore, lncRNA4474 promoted the expression of HNF-1β by inhibiting miR-615 expression, whereas miR-615 regulated the expression of HNF-1β and thus activated the Wnt signaling pathway. This study demonstrated that the overexpression of lncRNA4474 may attenuate fibrosis progression, accompanied by the downregulation of miR-615 and upregulation of HNF-1β. Hence, this study provides novel information that can be useful in the early diagnosis and treatment of renal fibrosis.

Entities:  

Keywords:  HNF-1β; Renal fibrosis; long noncoding RNA; miRNA; unilateral ureteral obstruction

Mesh:

Substances:

Year:  2022        PMID: 35230916      PMCID: PMC9132390          DOI: 10.1080/15384101.2022.2046982

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  30 in total

Review 1.  LncRNA: a link between RNA and cancer.

Authors:  Guodong Yang; Xiaozhao Lu; Lijun Yuan
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Extracellular microRNA signature in chronic kidney disease.

Authors:  Jagdeesan Muralidharan; Ali Ramezani; Monica Hubal; Susan Knoblach; Shashi Shrivastav; Sara Karandish; Richard Scott; Nirmal Maxwell; Savas Ozturk; Srinivasan Beddhu; Jeffrey B Kopp; Dominic S Raj
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-11

3.  Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance.

Authors:  Rémy Denzler; Vikram Agarwal; Joanna Stefano; David P Bartel; Markus Stoffel
Journal:  Mol Cell       Date:  2014-05-01       Impact factor: 17.970

4.  miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.

Authors:  Jizhao Wang; Lin Liu; Yuchen Sun; Yumo Xue; Jingkun Qu; Shupei Pan; Huajing Li; Hangying Qu; Jiansheng Wang; Jia Zhang
Journal:  Biomed Pharmacother       Date:  2018-03-22       Impact factor: 6.529

Review 5.  MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases.

Authors:  Xiao-Zhou Zou; Ting Liu; Zhi-Cheng Gong; Chang-Ping Hu; Zheng Zhang
Journal:  Eur J Pharmacol       Date:  2016-12-02       Impact factor: 4.432

Review 6.  Wnt/beta-catenin signaling: a promising new target for fibrosis diseases.

Authors:  Y Guo; L Xiao; L Sun; F Liu
Journal:  Physiol Res       Date:  2012-06-06       Impact factor: 1.881

7.  Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice.

Authors:  Junwei Yang; Chunsun Dai; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

Review 8.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

Review 9.  MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).

Authors:  Yuhe Lei; Lei Chen; Ge Zhang; Aiyun Shan; Chunfeng Ye; Bin Liang; Jiayu Sun; Xin Liao; Changfeng Zhu; Yueyue Chen; Jing Wang; Enxin Zhang; Lijuan Deng
Journal:  Oncol Rep       Date:  2020-07-23       Impact factor: 3.906

Review 10.  New insights into the role of HNF-1β in kidney (patho)physiology.

Authors:  Silvia Ferrè; Peter Igarashi
Journal:  Pediatr Nephrol       Date:  2018-07-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.